share_log

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38

HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Lowers Price Target to $38

HC Wainwright & Co.重申買入格林威治生命科學,將目標價下調至38美元
Benzinga ·  2023/04/10 12:10

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price target from $78 to $38.

HC Wainwright & Co. 分析師陳毅重申格林威治生命科學(納斯達克股票代碼:GLSI)的買入,並將目標股價從78美元下調至38美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論